Has Sandeep Mistry, MD received payments from drug or device companies?

Yes. Drug and device makers reported $147,552 in general payments to Sandeep Mistry, MD across 273 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sandeep Mistry, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sandeep Mistry, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sandeep Mistry, MD

Urology · Round Rock, TXNPI 1104039916

Payments from drug & device makers

$147,552in general payments, 2019–2025

Across 273 payments — averaging $540.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$68K
Laborie Medical Technologies Corp.$52K
Urovant Sciences Inc$10K
Uc-care (USA), Inc$4K
Sumitomo Pharma America, Inc.$3K
Axonics, Inc.$2K
plus $8K from 40 others

What the payments were for

Travel & lodging$8,12110%
Food & beverage$9,13811%
Education$65,15679%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	39	$67,761
Laborie Medical Technologies Corp.	22	$52,387
Urovant Sciences Inc	3	$10,250
Uc-care (USA), Inc	1	$4,308
Sumitomo Pharma America, Inc.	4	$2,518
Axonics, Inc.	30	$2,135
Boston Scientific	28	$1,394
Coloplast	14	$1,183
Angiodynamics, Inc.	9	$1,074
Neotract Inc.	4	$894
EDAP Technomed Inc	5	$474
AbbVie(2 entities)	18	$432
Abbott	6	$256
Novo Nordisk	7	$249
Procept Biorobotics Corporation	5	$231
Valencia Technologies Corporation	4	$224
180 Medical, Inc.	5	$205
Astellas Pharma US Inc	6	$174
Olympus America Inc.	6	$147
Ferring Pharmaceuticals Inc.	5	$111
Johnson & Johnson(2 entities)	5	$102
AMAG Pharmaceuticals, Inc.	5	$91
Bluewind Medical	2	$89
Urogen Pharma, Inc.	5	$89
Agiliti Surgical, Inc.	1	$70
Travere Therapeutics, Inc.	4	$67
Verity Pharmaceuticals Inc.	3	$57
Myriad Genetic Laboratories, Inc.	3	$56
Endo USA, Inc.	2	$49
Innovation Technologies Inc	1	$47
Smith+Nephew	2	$45
Hollister Incorporated	2	$43
Aytu Biopharma, Inc.	2	$36
Dendreon Pharmaceuticals LLC	1	$35
Teleflex LLC	2	$33
Endo Pharmaceuticals Inc.	2	$30
Mimedx Group, Inc.	1	$27
Siemens Medical Solutions USA, Inc.	1	$25
Telix Pharmaceuticals	1	$23
Clarus Therapeutics Inc.	1	$23
Calyxo, Inc.	1	$22
Pfizer	1	$20
Myovant Sciences Inc.	1	$19
Itamar Medical Inc	1	$19
E.r. Squibb & Sons, L.L.C.	1	$17
Therapeuticsmd, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$147,552 in reported general payments places this provider in the 90th percentile of 878 urology providers in Texas.

See all urology providers in Texas →

Medicare billing

Part B allowed, 2024

$450,086

Medicare patients

786

Services billed

9,732

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trospium Chloride ErTrospium Chloride	20	$2,901
Estradiol	20	$1,253
Silodosin	25	$1,108
Desmopressin Acetate	11	$641
Tamsulosin Hcl	32	$370
Alfuzosin Hcl ErAlfuzosin Hcl	21	$329
Oxybutynin Chloride ErOxybutynin Chloride	26	$189
Ciprofloxacin Hcl	49	$169
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	93	$125
Oxybutynin Chloride	14	$117

Paid to pharmacies, not to this prescriber.

Other urology in Round Rock

David CuellarRound Rock$391K
Zvi SchiffmanHouston$17.8M
Jose de la CerdaSan Antonio$9M
Daniel SaltzsteinSan Antonio$5.8M
Jose KaramHouston$5.7M
Daniel ZainfeldSan Antonio$4.7M
Brian MazzarellaLakeway$4.5M
Andrew von EschenbachMontgomery$3.2M
Raj SatkunasivamHouston$2.6M
Alan SkolnickHouston$2.4M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →